Machado-Joseph disease/spinocerebellar ataxia 3 responsive to buspirone
Identifieur interne : 003226 ( PascalFrancis/Corpus ); précédent : 003225; suivant : 003227Machado-Joseph disease/spinocerebellar ataxia 3 responsive to buspirone
Auteurs : J. H. FriedmanSource :
- Movement disorders [ 0885-3185 ] ; 1997.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
|
---|
Format Inist (serveur)
NO : | PASCAL 97-0411298 INIST |
---|---|
ET : | Machado-Joseph disease/spinocerebellar ataxia 3 responsive to buspirone |
AU : | FRIEDMAN (J. H.) |
AF : | Memorial Hospital of Rhode Island, Dept. of Clinical Neurosciences, Brown University School of Medicine/Etats-Unis (1 aut.) |
DT : | Publication en série; Niveau analytique |
SO : | Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 1997; Vol. 12; No. 4; Pp. 613-614; Bibl. 8 ref. |
LA : | Anglais |
CC : | 002B02B03 |
FD : | Joseph maladie; Hérédodégénérescence spinocérébelleuse; Buspirone; Psychotrope; Chimiothérapie; Traitement; Homme; Mâle; Etude cas |
FG : | Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Maladie dégénérative; Métabolisme pathologie; Enzymopathie; Aminoacidopathie; Moelle épinière pathologie; Maladie héréditaire |
ED : | Joseph disease; Spinocerebellar heredodegeneration; Buspirone; Psychotropic; Chemotherapy; Treatment; Human; Male; Case study |
EG : | Nervous system diseases; Central nervous system disease; Cerebral disorder; Degenerative disease; Metabolic diseases; Enzymopathy; Aminoacid disorder; Spinal cord disease; Genetic disease |
GD : | Aufbereiten |
SD : | Joseph enfermedad; Heredodegeneración espinocerebelosa; Buspirona; Psicotropo; Quimioterapia; Tratamiento; Hombre; Macho; Estudio caso |
LO : | INIST-20953.354000067729910250 |
ID : | 97-0411298 |
Links to Exploration step
Pascal:97-0411298Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Machado-Joseph disease/spinocerebellar ataxia 3 responsive to buspirone</title>
<author><name sortKey="Friedman, J H" sort="Friedman, J H" uniqKey="Friedman J" first="J. H." last="Friedman">J. H. Friedman</name>
<affiliation><inist:fA14 i1="01"><s1>Memorial Hospital of Rhode Island, Dept. of Clinical Neurosciences, Brown University School of Medicine</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">97-0411298</idno>
<date when="1997">1997</date>
<idno type="stanalyst">PASCAL 97-0411298 INIST</idno>
<idno type="RBID">Pascal:97-0411298</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003226</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Machado-Joseph disease/spinocerebellar ataxia 3 responsive to buspirone</title>
<author><name sortKey="Friedman, J H" sort="Friedman, J H" uniqKey="Friedman J" first="J. H." last="Friedman">J. H. Friedman</name>
<affiliation><inist:fA14 i1="01"><s1>Memorial Hospital of Rhode Island, Dept. of Clinical Neurosciences, Brown University School of Medicine</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1997">1997</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Buspirone</term>
<term>Case study</term>
<term>Chemotherapy</term>
<term>Human</term>
<term>Joseph disease</term>
<term>Male</term>
<term>Psychotropic</term>
<term>Spinocerebellar heredodegeneration</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Joseph maladie</term>
<term>Hérédodégénérescence spinocérébelleuse</term>
<term>Buspirone</term>
<term>Psychotrope</term>
<term>Chimiothérapie</term>
<term>Traitement</term>
<term>Homme</term>
<term>Mâle</term>
<term>Etude cas</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>12</s2>
</fA05>
<fA06><s2>4</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Machado-Joseph disease/spinocerebellar ataxia 3 responsive to buspirone</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>FRIEDMAN (J. H.)</s1>
</fA11>
<fA14 i1="01"><s1>Memorial Hospital of Rhode Island, Dept. of Clinical Neurosciences, Brown University School of Medicine</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA20><s1>613-614</s1>
</fA20>
<fA21><s1>1997</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000067729910250</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 1997 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>8 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>97-0411298</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B02B03</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Joseph maladie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Joseph disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Joseph enfermedad</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Hérédodégénérescence spinocérébelleuse</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Spinocerebellar heredodegeneration</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Heredodegeneración espinocerebelosa</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Buspirone</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Buspirone</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Buspirona</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Psychotrope</s0>
<s2>FX</s2>
<s5>08</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Psychotropic</s0>
<s2>FX</s2>
<s5>08</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Psicotropo</s0>
<s2>FX</s2>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Chimiothérapie</s0>
<s5>16</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Chemotherapy</s0>
<s5>16</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Quimioterapia</s0>
<s5>16</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Traitement</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Treatment</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="GER"><s0>Aufbereiten</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>17</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Mâle</s0>
<s5>21</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Male</s0>
<s5>21</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Macho</s0>
<s5>21</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Etude cas</s0>
<s5>23</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Case study</s0>
<s5>23</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Estudio caso</s0>
<s5>23</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Métabolisme pathologie</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Metabolic diseases</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Metabolismo patología</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Enzymopathie</s0>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Enzymopathy</s0>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Enzimopatía</s0>
<s5>42</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Aminoacidopathie</s0>
<s5>43</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Aminoacid disorder</s0>
<s5>43</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Aminoacido alteración</s0>
<s5>43</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Moelle épinière pathologie</s0>
<s5>47</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Spinal cord disease</s0>
<s5>47</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Médula espinal patología</s0>
<s5>47</s5>
</fC07>
<fC07 i1="09" i2="X" l="FRE"><s0>Maladie héréditaire</s0>
<s5>50</s5>
</fC07>
<fC07 i1="09" i2="X" l="ENG"><s0>Genetic disease</s0>
<s5>50</s5>
</fC07>
<fC07 i1="09" i2="X" l="SPA"><s0>Enfermedad hereditaria</s0>
<s5>50</s5>
</fC07>
<fN21><s1>251</s1>
</fN21>
</pA>
</standard>
<server><NO>PASCAL 97-0411298 INIST</NO>
<ET>Machado-Joseph disease/spinocerebellar ataxia 3 responsive to buspirone</ET>
<AU>FRIEDMAN (J. H.)</AU>
<AF>Memorial Hospital of Rhode Island, Dept. of Clinical Neurosciences, Brown University School of Medicine/Etats-Unis (1 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 1997; Vol. 12; No. 4; Pp. 613-614; Bibl. 8 ref.</SO>
<LA>Anglais</LA>
<CC>002B02B03</CC>
<FD>Joseph maladie; Hérédodégénérescence spinocérébelleuse; Buspirone; Psychotrope; Chimiothérapie; Traitement; Homme; Mâle; Etude cas</FD>
<FG>Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Maladie dégénérative; Métabolisme pathologie; Enzymopathie; Aminoacidopathie; Moelle épinière pathologie; Maladie héréditaire</FG>
<ED>Joseph disease; Spinocerebellar heredodegeneration; Buspirone; Psychotropic; Chemotherapy; Treatment; Human; Male; Case study</ED>
<EG>Nervous system diseases; Central nervous system disease; Cerebral disorder; Degenerative disease; Metabolic diseases; Enzymopathy; Aminoacid disorder; Spinal cord disease; Genetic disease</EG>
<GD>Aufbereiten</GD>
<SD>Joseph enfermedad; Heredodegeneración espinocerebelosa; Buspirona; Psicotropo; Quimioterapia; Tratamiento; Hombre; Macho; Estudio caso</SD>
<LO>INIST-20953.354000067729910250</LO>
<ID>97-0411298</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003226 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 003226 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PascalFrancis |étape= Corpus |type= RBID |clé= Pascal:97-0411298 |texte= Machado-Joseph disease/spinocerebellar ataxia 3 responsive to buspirone }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |